Abzena is a biologics research partner that specializes in providing services and technologies for the development and manufacture of biopharmaceutical products globally, including in North America and Europe. The company focuses on biologics and antibody-drug conjugates (ADCs), offering solutions that span from early discovery to mid-phase biotherapeutic and bioconjugation drug development. Abzena's service offerings include antibody and protein engineering, developability assessment, immunogenicity assessment, and various bioassays and bioanalytics. Additionally, it provides expertise in ADC manufacturing and peptide synthesis. By serving biopharmaceutical companies and academic groups, Abzena aims to enhance the development of innovative treatments for patients. Established in 2014 and headquartered in Cambridge, United Kingdom, Abzena has positioned itself as a key player in the biopharmaceutical industry.
PacificGMP Inc. is a contract manufacturing organization, engages in developing and manufacturing biologics. It produces monoclonal antibodies, recombinant proteins, vaccine products, insect cell/baculovirus, anchorage and suspension cells, and gene therapy products.
PolyTherics
Acquisition in 2013
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
Antitope
Acquisition in 2013
Antitope Ltd is a biotechnology research company, develops non-immunogenic protein therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.